-
s Osteopontin in CardioMetabolic Medicine: A Risk Stratification Biomarker with Future Therapeutic Implication
- Source: Current Medicinal Chemistry, Volume 29, Issue 25, Aug 2022, p. 4314 - 4316
-
- 01 Aug 2022
Preview this article:




Osteopontin in CardioMetabolic Medicine: A Risk Stratification Biomarker with Future Therapeutic Implication, Page 1 of 1
< Previous page Next page > /docserver/preview/fulltext/cmc/29/25/s5-1.gif
There is no abstract available.
© Bentham Science Publishers